Mar 14, 2023 / 05:20PM GMT
Leland Gershell - Oppenheimer & Co. Inc. - Analyst
Thanks. Good afternoon, everyone. Welcome back to another session here at Oppenheimer's 33rd Annual Healthcare Conference. I'm Leland Gershell, one of the analysts on the biotech equity research team, and very delighted to have with us Protara Therapeutics as our next presenting company.
If you've been following our research, you know that we like the TARA story very much and, on behalf of Protara, we have the company's CEO, Jesse Shefferman, who will walk through the story. We will have some time for Q&A at the end, so please submit any questions you have through Zoom or you can e-mail me at [email protected]. And with that, I'll hand it over to Jesse.
Jesse Shefferman - Protara Therapeutics, Inc. - Co-founder, Director, CEO
All right. Thanks, Leland and the whole Oppenheimer team for having us here. On our next slide, we have a brief pause on standard disclaimers, which we're just actually just going to get through. Protara is a New York-based biotech. We're focused on oncology and rare
Protara Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 14, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers